Invitro Maturation of Oocytes for Patients With Polycystic Ovaries
NCT ID: NCT00631982
Last Updated: 2008-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF
NCT00561808
Comparison Between Two Fertility Protocols in Obese Polycystic Ovary Syndrome Patients
NCT01473459
Improving in Vitro Fertilization in Women With Poor Ovarian Response
NCT04024722
OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol
NCT03881904
Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1
NCT00883766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Needing IVF for fertility treatment
Exclusion Criteria
18 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assaf-Harofeh Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Assaf Harofeh Medical Center, Zerifin Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVF and Infertility Unit, Assaf Harofeh Medical Center
Ẕerifin, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Raphael Ron - El, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Raphael Ron-El, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.